{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:49:56Z","timestamp":1790009396904,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.lungcan.2021.06.020","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T11:56:48Z","timestamp":1626436608000},"page":"84-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition"],"prefix":"10.1016","volume":"159","author":[{"given":"Florian","family":"Kocher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Tymoszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Salcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rinnerthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Kauffmann-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2021.06.020_b0005","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2020, CA: a cancer journal for clinicians 70(1) (2020) 7-30.","DOI":"10.3322\/caac.21590"},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/annonc\/mdw611","article-title":"Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial","volume":"28","author":"Paz-Ares","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2021.06.020_b0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1470-2045(17)30339-X","article-title":"Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial","volume":"18","author":"Shaw","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"New Engl. J. Med."},{"issue":"19","key":"10.1016\/j.lungcan.2021.06.020_b0025","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"New Engl. J. Med."},{"issue":"10066","key":"10.1016\/j.lungcan.2021.06.020_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","article-title":"Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts","volume":"61","author":"Hamanaka","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lungcan.2021.06.020_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-152825-6.50008-4","article-title":"The regulatory functions of proline and pyrroline-5-carboxylic acid","volume":"25","author":"Phang","year":"1985","journal-title":"Curr. Top. Cell. Regul."},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bjc.2017.387","article-title":"MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer","volume":"118","author":"Craze","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"28","key":"10.1016\/j.lungcan.2021.06.020_b0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016384","article-title":"The clinical significance of PYCR1 expression in renal cell carcinoma","volume":"98","author":"Weijin","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.lungcan.2021.06.020_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-1","article-title":"Prolyl-4-hydroxylase alpha subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition","volume":"14","author":"Xiong","year":"2014","journal-title":"BMC cancer"},{"key":"10.1016\/j.lungcan.2021.06.020_b0060","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10089","article-title":"Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung","volume":"8","author":"Dong","year":"2020","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.lungcan.2021.06.020_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061510","article-title":"Serum type XIX collagen is significantly elevated in non-small cell lung cancer: a preliminary study on biomarker potential","volume":"12","author":"Thorlacius-Ussing","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cas.14257","article-title":"Integrin \u03b111 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence","volume":"111","author":"Ando","year":"2020","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","article-title":"An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates","volume":"37","author":"Goveia","year":"2020","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2021.06.020_b0085","doi-asserted-by":"crossref","unstructured":"P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G. Cleland, A.J. Coats, V. Falk, J.R. Gonzalez-Juanatey, V.P. Harjola, E.A. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, J.T. Parissis, B. Pieske, J.P. Riley, G.M. Rosano, L.M. Ruilope, F. Ruschitzka, F.H. Rutten, P. van der Meer, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, European journal of heart failure 18(8) (2016) 891-975.","DOI":"10.1002\/ejhf.592"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.lungcan.2021.06.020_b0095","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.lungcan.2021.06.020_b0100","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Xu, Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.lungcan.2021.06.020_b0105","doi-asserted-by":"crossref","unstructured":"H. Liu, K. Naxerova, M. Pinter, J. Incio, H. Lee, K. Shigeta, W.W. Ho, J.A. Crain, A. Jacobson, T. Michelakos, D. Dias-Santos, A. Zanconato, T.S. Hong, J.W. Clark, J.E. Murphy, D.P. Ryan, V. Deshpande, K.D. Lillemoe, C. Fernandez-Del Castillo, M. Downes, R.M. Evans, J. Michaelson, C.R. Ferrone, Y. Boucher, R.K. Jain, Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma, Clinical cancer research : an official journal of the American Association for Cancer Research 23(19) (2017) 5959-5969.","DOI":"10.1158\/1078-0432.CCR-17-0256"},{"issue":"10","key":"10.1016\/j.lungcan.2021.06.020_b0110","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1158\/1055-9965.EPI-10-0332","article-title":"Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women","volume":"19","author":"Lu","year":"2010","journal-title":"Cancer Epidemiol., Biomarkers Prevent."},{"issue":"186","key":"10.1016\/j.lungcan.2021.06.020_b0115","doi-asserted-by":"crossref","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","article-title":"Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers","volume":"5","author":"Rousseaux","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2021.06.020_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.136","article-title":"A merged lung cancer transcriptome dataset for clinical predictive modeling","volume":"5","author":"Lim","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.lungcan.2021.06.020_b0125","doi-asserted-by":"crossref","unstructured":"Comprehensive genomic characterization of squamous cell lung cancers, Nature 489(7417) (2012) 519-25.","DOI":"10.1038\/nature11404"},{"key":"10.1016\/j.lungcan.2021.06.020_b0130","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular profiling of lung adenocarcinoma, Nature 511(7511) (2014) 543-50.","DOI":"10.1038\/nature13385"},{"key":"10.1016\/j.lungcan.2021.06.020_b0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2105-12-474","article-title":"Jetset: selecting the optimal microarray probe set to represent a gene","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen robust multiarray analysis (fRMA)","volume":"11","author":"McCall","year":"2010","journal-title":"Biostatistics (Oxford, England)"},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020428","article-title":"The Impact of Cand1 in Prostate Cancer","volume":"12","author":"Eigentler","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bioinformatics\/btn577","article-title":"A novel signaling pathway impact analysis","volume":"25","author":"Tarca","year":"2008","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0155","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.lungcan.2021.06.020_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.lungcan.2021.06.020_b0165","doi-asserted-by":"crossref","unstructured":"F. Kocher, M. Fiegl, M. Mian, W. Hilbe, Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth Considering, Clinical lung cancer (2014).","DOI":"10.1016\/j.cllc.2014.12.007"},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0170","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.cllc.2015.02.003","article-title":"Liver transplantation-associated lung cancer: comparison of clinical parameters and outcomes","volume":"16","author":"Kocher","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2014.12.006","article-title":"Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry","volume":"87","author":"Kocher","year":"2015","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.lungcan.2021.06.020_b0180","doi-asserted-by":"crossref","unstructured":"F. Kocher, F. Lunger, A. Seeber, A. Amann, A. Pircher, W. Hilbe, M. Fiegl, Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis, Clinical lung cancer 17(1) (2016) 62-7 e1.","DOI":"10.1016\/j.cllc.2015.08.006"},{"issue":"3","key":"10.1016\/j.lungcan.2021.06.020_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092511","article-title":"Development of an innovative 3D cell culture system to study tumour\u2013stroma interactions in non-small cell lung cancer cells","volume":"9","author":"Amann","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10585-008-9209-8","article-title":"Three-dimensional context regulation of metastasis","volume":"26","author":"Erler","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci. Am."},{"issue":"3","key":"10.1016\/j.lungcan.2021.06.020_b0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drup.2007.03.001","article-title":"Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery","volume":"10","author":"Bouzin","year":"2007","journal-title":"Drug Resistance Updates"},{"issue":"10","key":"10.1016\/j.lungcan.2021.06.020_b0205","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2021.06.020_b0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00006676-200305000-00003","article-title":"Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome","volume":"26","author":"Watanabe","year":"2003","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.lungcan.2021.06.020_b0215","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0220","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3892\/or.2014.3438","article-title":"Overexpression of type VI collagen in neoplastic lung tissues","volume":"32","author":"Voiles","year":"2014","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0225","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/1878-0261.12937","article-title":"Cancer-associated fibroblast migration in non-small cell lung cancers is modulated by increased integrin \u03b111 expression","volume":"15","author":"Iwai","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0230","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41467-018-06893-9","article-title":"Collagen prolyl 4-hydroxylase 1 is essential for HIF-1alpha stabilization and TNBC chemoresistance","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010062","article-title":"Lysyl oxidase and the tumor microenvironment","volume":"18","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"42","key":"10.1016\/j.lungcan.2021.06.020_b0240","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/onc.2014.467","article-title":"CACNA2D2 promotes tumorigenesis by stimulating cell proliferation and angiogenesis","volume":"34","author":"Warnier","year":"2015","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.lungcan.2021.06.020_b0245","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1007\/s13277-015-4734-y","article-title":"SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer","volume":"37","author":"Cheng","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lungcan.2021.06.020_b0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-020-01183-1","article-title":"CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment","volume":"20","author":"Sun","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188435","article-title":"LOXL2 in cancer: regulation, downstream effectors and novel roles","volume":"1874","author":"Wen","year":"2020","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0260","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"Saatci","year":"2020","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.lungcan.2021.06.020_b0265","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1021\/bi020582s","article-title":"Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen","volume":"42","author":"Moilanen","year":"2003","journal-title":"Biochemistry"},{"issue":"45","key":"10.1016\/j.lungcan.2021.06.020_b0270","doi-asserted-by":"crossref","first-page":"28509","DOI":"10.1074\/jbc.271.45.28509","article-title":"Different collagenase gene products have different roles in degradation of type I collagen","volume":"271","author":"Krane","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0275","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.21868","article-title":"ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice","volume":"46","author":"Kesteloot","year":"2007","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"10","key":"10.1016\/j.lungcan.2021.06.020_b0280","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00432-009-0587-3","article-title":"Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy","volume":"135","author":"Wilop","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2021.06.020_b0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","article-title":"Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31)","volume":"23","author":"Lertkiatmongkol","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.lungcan.2021.06.020_b0290","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","article-title":"Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy","volume":"6","author":"Incio","year":"2016","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.lungcan.2021.06.020_b0295","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2362.2008.02025.x","article-title":"Angiotensin inhibition stimulates PPARgamma and the release of visfatin","volume":"38","author":"Storka","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2021.06.020_b0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejphar.2016.08.040","article-title":"Ramipril restores PPAR\u03b2\/\u03b4 and PPAR\u03b3 expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat","volume":"791","author":"Cernecka","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lungcan.2021.06.020_b0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-11-21","article-title":"Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells","volume":"11","author":"Tan","year":"2010","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.lungcan.2021.06.020_b0310","doi-asserted-by":"crossref","first-page":"L891","DOI":"10.1152\/ajplung.00333.2007","article-title":"PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis","volume":"294","author":"Milam","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.lungcan.2021.06.020_b0315","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","article-title":"Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer","volume":"328","author":"Chen","year":"2013","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.lungcan.2021.06.020_b0320","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1097\/00029330-200811010-00012","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model","volume":"121","author":"Wang","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"8","key":"10.1016\/j.lungcan.2021.06.020_b0325","first-page":"614","article-title":"Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts","volume":"65","author":"Karna","year":"2010","journal-title":"Pharmazie"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221004670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221004670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:54:05Z","timestamp":1759236845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500221004670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":65,"alternative-id":["S0169500221004670"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.06.020","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}